Impact Careers Full-time

Senior Scientist, Immunology

Recursion

Posted

Jan 18, 2026

Location

UK

Type

Full-time

Compensation

£70400 - £93500

Mission

What you will drive

Core responsibilities:

  • Design and execute complex in vitro assays using primary human immune cells and patient-derived tissues for target validation, mechanism of action studies, and small molecule screening
  • Drive projects through the entire development lifecycle, from initial target ideation and validation to formal adoption into the company portfolio
  • Deploy state-of-the-art technologies such as flow cytometry and high-content imaging to address key scientific questions
  • Lead scientific initiatives and early drug discovery programs by evaluating the latest scientific developments and managing external collaborations

Impact

The difference you'll make

This role creates positive change by advancing drug discovery through innovative immunology research, working to uncover solutions for therapeutic projects that can radically improve lives through the development of new medicines.

Profile

What makes you a great fit

Required qualifications:

  • Ph.D in Immunology or related discipline OR BSc/MSc degree with significant relevant experience in pharmaceutical/biotechnology industry
  • Extensive hands-on experience designing, executing and optimizing in vitro assays utilizing primary human immune cells/patient derived tissue
  • In-depth understanding of gut inflammation and knowledge of in vitro relevant translational and in vivo models
  • Experience screening small molecules and working on drug discovery programs with knowledge of data analysis including dose response relationships

Benefits

What's in it for you

Compensation and benefits:

  • Estimated annual base salary range: £70,400 to £93,500
  • Eligible for annual bonus and equity compensation
  • Comprehensive benefits package
  • Values-driven culture emphasizing bold action with integrity, deep care and engagement, active learning and rapid adaptation, urgency for patients, ownership and accountability, and cross-functional collaboration